A study of depressed individuals found that an eight‐week treatment with selective serotonin reuptake inhibitors (SSRIs) ...

Speaking in depth about her depression, Welch shared the tell-tale signs that occur in her body when a depressive episode is ...

Antibiotics can disturb the microbiome and affect how people process emotions. This can sometimes heighten negative emotions ...

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

Supernus Pharmaceuticals may have had a potential path forward for its depression drug candidate cut off after the asset ...

A two-part clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE is testing the use of ...

Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...

Supernus' SPN-820 Phase 2b study in treatment-resistant depression failed to meet its primary endpoint, prompting further ...

Faster-acting drugs have long been sought to protect people with severe depression who may be at risk of self-harm or suicide ...

The Royal Devon University Healthcare NHS Foundation Trust is leading ground-breaking clinical research that has the potential to transform treatments for neuropsychiatric disorders.